MedcryptCase Study: Elevating Post-Market Vigilance Through Enhanced Vulnerability DetectionIntroduction5 min read·5 hours ago----
MedcryptAre all SBOM tools created equal?Buyers guide for SBOM vulnerability management tools4 min read·6 days ago----
MedcryptinMedcrypt Medical Device Cybersecurity BlogsAre SBOMs moving the needle for improving medical device cybersecurity?By Om Mahida, Medcrypt VP of Product5 min read·Mar 28, 2024----
MedcryptinMedcrypt Medical Device Cybersecurity BlogsDirectors, VPs, and C-Suite Executives’ Approach to FDA Stock Deficiency Letters (Part 4/4)By Naomi Schwartz, Medcrypt VP of Services5 min read·Mar 19, 2024----
MedcryptinMedcrypt Medical Device Cybersecurity BlogsRegulatory Affairs’ Approach to FDA Stock Deficiency Letters (Part 3/4)By Ira Owens, Medcrypt Director of Cybersecurity and Ayushi Soni, Medcrypt Cybersecurity Intern3 min read·Mar 18, 2024----
MedcryptinMedcrypt Medical Device Cybersecurity BlogsProduct Engineers’ Approach to FDA Stock Deficiency Letters (Part 2/4)By Ira Owens, Medcrypt Director of Cybersecurity4 min read·Mar 13, 2024----
MedcryptinMedcrypt Medical Device Cybersecurity BlogsFDA is issuing deficiency letters- why you should care (Part 1/4)By Naomi Schwartz, Medcrypt VP of Services7 min read·Mar 12, 2024----
MedcryptinMedcrypt Medical Device Cybersecurity BlogsPart 2: HHS Wall of Shame Analysis 2009–2023 — Changing Regulatory EnvironmentBy Vidya Murthy, Medcrypt COO and Axel Wirth, Medcrypt CSS5 min read·Mar 1, 2024----
MedcryptinMedcrypt Medical Device Cybersecurity BlogsHHS Wall of Shame Analysis 2009–2023 — Things Ain’t Getting Better (Part 1/2)By Axel Wirth3 min read·Feb 26, 2024----
MedcryptMedical Device Cybersecurity — 2023 Learnings and 2024 ExpectationsBy Axel Wirth, Chief Security Strategist, Medcrypt5 min read·Dec 18, 2023----